| Profile | GDS1873 / 212018_s_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 1678.28 | 93 |
| GSM40788 | control - Rep 2 | 952.379 | 88 |
| GSM40789 | control - Rep 3 | 998 | 89 |
| GSM40775 | androgen treated - Rep 1 | 1034.65 | 89 |
| GSM40776 | androgen treated - Rep 2 | 1246.37 | 91 |
| GSM40777 | androgen treated - Rep 3 | 1187.4 | 91 |
| GSM40790 | estrogen treated - Rep 1 | 1033.93 | 89 |
| GSM40791 | estrogen treated - Rep 2 | 1519.43 | 93 |
| GSM40792 | estrogen treated - Rep 3 | 1353.08 | 91 |
| GSM40784 | A + tamoxifen - Rep 1 | 1229.83 | 91 |
| GSM40785 | A + tamoxifen - Rep 2 | 1314.03 | 92 |
| GSM40786 | A + tamoxifen - Rep 3 | 1360.18 | 92 |
| GSM40778 | A + anastrozole - Rep 1 | 932.213 | 89 |
| GSM40779 | A + anastrozole - Rep 2 | 1364.08 | 91 |
| GSM40780 | A + anastrozole - Rep 3 | 1223.13 | 91 |
| GSM40781 | A + letrozole - Rep 1 | 737.36 | 86 |
| GSM40782 | A + letrozole - Rep 2 | 1171.7 | 90 |
| GSM40783 | A + letrozole - Rep 3 | 1349.39 | 92 |